Kenneth Horton
General Counsel bij SENSEONICS HOLDINGS, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Kenneth L.
Horton is currently the General Counsel at Senseonics Holdings, Inc. He previously served as the Chairman at Lumira Capital (USA) Corp.
From 2012 to 2015, he was the Chief Legal Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. Kenneth also held the position of VP-Acquisitions, Ventures & General Counsel at Revvity, Inc. Prior to that, he was the EVP-Corporate Development & General Counsel at Nordion (Canada), Inc. from 2005 to 2012.
Mr. Horton completed his undergraduate studies at Dartmouth College and obtained his graduate degree from Harvard Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2024 | 1 947 186 ( 0.37% ) | 1 M $ | 31-03-2024 |
Actieve functies van Kenneth Horton
| Bedrijven | Functie | Begin |
|---|---|---|
| SENSEONICS HOLDINGS, INC. | General Counsel | 01-10-2017 |
Eerdere bekende functies van Kenneth Horton
| Bedrijven | Functie | Einde |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 20-01-2015 |
| NORDION INC | General Counsel | 01-01-2012 |
| Lumira Capital (USA) Corp. | Chairman | - |
| REVVITY, INC. | Corporate Officer/Principal | - |
Opleiding van Kenneth Horton
| Dartmouth College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| REVVITY, INC. | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
| Lumira Capital (USA) Corp. |
